Afatinib CAS:439081-18-2

Afatinib  CAS:439081-18-2
Product Details

Product Information

CAS NO.439081-18-2 7.png
Product NameAfatinib
Molecular Weight485.94
Spec / Purity98%min
Supply Capacity
DetailsAfatinib is a drug approved in United States, Europe, Taiwan, Mexico, Chile and Japan as well as other countries for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC). It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2).

If you are going to consult the information about afatinib cas:439081-18-2 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.